Last week’s highly regarded Pharmaceutical Market Excellence Awards (PMEAs) featured incredible examples of the impact we can make to the lives of patients, families and healthcare professionals. Congratulations to all the winners and nominees.
We are thrilled to have been there and to have brought home the award for Excellence in Patient Education and Support collaborating with Novartis, The Clarion Portfolio and Salt.
Failure: Reprioritising Heart Failure Care in the UK
failure (HF) is a condition that is becoming increasingly prevalent but is
poorly recognised. Almost 1 million people in the UK are currently living with
HF, with a further 200,000 new patients diagnosed each year.
a disparity of care across the country, we had to act and create a campaign
that would increase the level of understanding of HF in the UK and drive
improved diagnosis, care and quality of life for patients. In-depth research
and insights gathering confirmed that there was a significant challenge ahead
of us. We needed to create a campaign to drive change in HF, but we knew we
could not do this alone.
closely with healthcare professionals and patients was key and the only path
that could make a difference. With partnership at the heart of the campaign,
the strategic direction became clear. By the people, for the people.
Fighting Failure campaign has created practical resources for the HF community
and a spirit to help motivate those living with the disease to seek improvement
in their quality of life.
the judges’ commented: “It had bold ambition across UK stakeholders and
focused on the need for information. Exceeded expectations.”